Seeing Is Believing
Currently out of the existing stock ratings of John Sourbeer, 37 are a BUY (51.39%), 34 are a HOLD (47.22%), 1 are a SELL (1.39%).
Analyst John Sourbeer works at UBS with a stock forecast success ratio of 43.68% fulfilled within 50.63 days on average.
John Sourbeerās has documented 148 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Industrials, ļ»æBasic Materials sectors.
Most recent stock forecast was given on BRKR, Bruker at 01-Mar-2024.
Analyst best performing recommendations are on OCDX (ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC).
The best stock recommendation documented was for OCDX (ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC) at 2/17/2022. The price target of $17 was fulfilled within 1 day with a profit of $0.83 (5.13%) receiving and performance score of 51.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
18.19
$0.56 (3.18%)
24
1 years 10 months 22 days ago
0/2 (0%)
$0.83 (4.78%)
Hold
17
$-0.63 (-3.57%)
28
2 years 1 months 11 days ago
1/3 (33.33%)
$0.83 (5.13%)
1
Buy
21
$3.37 (19.12%)
2 years 1 months 11 days ago
0/3 (0%)
$4.83 (29.87%)
Hold
20
$2.37 (13.44%)
25
2 years 1 months 11 days ago
0/6 (0%)
$3.83 (23.69%)
Hold
24.68
$7.05 (39.99%)
24.68
2 years 2 months 26 days ago
0/2 (0%)
$3.29 (15.38%)
Which stock is John Sourbeer is most bullish on?
Which stock is John Sourbeer is most reserved on?
What Year was the first public recommendation made by John Sourbeer?